Friday, June 27, 2014

diabetes : CHMP Recommends Lilly and Boehringer ...

Search for the latest updates on diabetes


News

CHMP Recommends Lilly and Boehringer Ingelheim's Investigational New Insulin Glargine Product for Approval in the ... PR Newswire via Yahoo! Canada Finance  - 11 minutes
INDIANAPOLIS and RIDGEFIELD, Conn., June 27, 2014 /PRNewswire/ -- The Committee for Medicinal Products for Human Use (CHMP) today issued a ...

CHMP Recommends Lilly and Boehringer Ingelheim's New Insulin Glargine Product for Approval in the European Union PR Newswire via Yahoo! Canada Finance  - 11 minutes
INDIANAPOLIS and INGELHEIM, Germany, June 27, 2014 /PRNewswire/ -- The Committee for Medicinal Products for Human Use (CHMP) today issued a ...

EYLEA® (aflibercept) Injection Recommended for Approval for the Treatment of Visual Impairment due to Diabetic Macular ... PR Newswire via Yahoo! Canada Finance  - 54 minutes
TARRYTOWN, N.Y., June 27, 2014 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (REGN) today announced that EYLEA® (aflibercept) Injection has ...

Current diabetes news »

Search for the latest updates on diabetes

Manage alerts  ·   Unsubscribe  ·   Privacy Policy

 
Tip: To search for an exact phrase, put quotation marks around two or more words.
 
You received this email because you subscribed to Yahoo! Alerts.

No comments:

Post a Comment